1. Home
  2. DLPN vs NLSP Comparison

DLPN vs NLSP Comparison

Compare DLPN & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DLPN
  • NLSP
  • Stock Information
  • Founded
  • DLPN 1996
  • NLSP 2015
  • Country
  • DLPN United States
  • NLSP Switzerland
  • Employees
  • DLPN N/A
  • NLSP N/A
  • Industry
  • DLPN Other Consumer Services
  • NLSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • DLPN Consumer Discretionary
  • NLSP Health Care
  • Exchange
  • DLPN Nasdaq
  • NLSP Nasdaq
  • Market Cap
  • DLPN 12.6M
  • NLSP 12.4M
  • IPO Year
  • DLPN N/A
  • NLSP 2021
  • Fundamental
  • Price
  • DLPN $1.19
  • NLSP $2.15
  • Analyst Decision
  • DLPN Strong Buy
  • NLSP
  • Analyst Count
  • DLPN 1
  • NLSP 0
  • Target Price
  • DLPN $5.00
  • NLSP N/A
  • AVG Volume (30 Days)
  • DLPN 580.9K
  • NLSP 210.7K
  • Earning Date
  • DLPN 08-13-2025
  • NLSP 10-17-2025
  • Dividend Yield
  • DLPN N/A
  • NLSP N/A
  • EPS Growth
  • DLPN N/A
  • NLSP N/A
  • EPS
  • DLPN N/A
  • NLSP N/A
  • Revenue
  • DLPN $51,257,243.00
  • NLSP N/A
  • Revenue This Year
  • DLPN $9.05
  • NLSP N/A
  • Revenue Next Year
  • DLPN $15.42
  • NLSP N/A
  • P/E Ratio
  • DLPN N/A
  • NLSP N/A
  • Revenue Growth
  • DLPN 4.84
  • NLSP N/A
  • 52 Week Low
  • DLPN $0.75
  • NLSP $1.30
  • 52 Week High
  • DLPN $1.78
  • NLSP $6.97
  • Technical
  • Relative Strength Index (RSI)
  • DLPN 51.86
  • NLSP 48.82
  • Support Level
  • DLPN $1.14
  • NLSP $1.88
  • Resistance Level
  • DLPN $1.21
  • NLSP $2.02
  • Average True Range (ATR)
  • DLPN 0.07
  • NLSP 0.15
  • MACD
  • DLPN 0.00
  • NLSP -0.03
  • Stochastic Oscillator
  • DLPN 77.27
  • NLSP 29.25

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

Share on Social Networks: